Artivion (NYSE:AORT – Get Free Report) had its target price reduced by equities research analysts at Stifel Nicolaus from $33 ...

Artivion, Inc. (NYSE:AORT – Get Free Report)’s stock price gapped down before the market opened on Tuesday following a dissappointing earnings announcement. The stock had previously closed at $27.85, ...

What Happened? Shares of medical device company Artivion (NYSE:AORT) fell 11.2% in the morning session after the company ...

It's been a mediocre week for Artivion, Inc. ( NYSE:AORT ) shareholders, with the stock dropping 13% to US$25.42 in ...

Medical device company Artivion (NYSE:AORT) in Q4 CY2024 as sales rose 3.9% year on year to $97.31 million. The company’s ...

Needham lowered the firm’s price target on Artivion (AORT) to $32 from $34 and keeps a Buy rating on the shares after its Q4 ...

Stifel lowered the firm’s price target on Artivion (AORT) to $30 from $33 and keeps a Buy rating on the shares after Q4 consensus sales ...

A suspicious stock trade by Senator Tina Smith saw a $100,000 to $200,000 investment in Artivion, which has since doubled in ...

In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on Artivion (AORT – Research Report), with a price target ...

The Kennesaw, Georgia-based company said it had a loss of 39 cents per share. Earnings, adjusted for one-time gains and costs, were less than 1 cent on a per-share basis. The biological medical device ...

ARTIVION ($AORT) is expected to release its quarterly earnings data on Monday, February 24th after market close, per Finnhub. Analysts are expecting revenue of ...